SR
Srinivasmurthy Ranganath
About Srinivasmurthy Ranganath
Data last updated:
Srinivasmurthy Ranganath is an Additional Director at Genlyfe Healthcare Private Limited (since 2025), Director at Jr Jenika Pharma Private Limited (since 2025) and Director at Jr Vajra Super Speciality Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Genlyfe Healthcare Private Limited at ₹41.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genlyfe Healthcare Private Limited U46497KA2023PTC171126 | Additional Director | 19 Nov 2025 | 2023 | ₹41.4 Lakh (FY 2024) | Active |
| Jr Jenika Pharma Private Limited U46497KA2025PTC199996 | Director | 21 Mar 2025 | 2025 | Active | |
| Jr Vajra Super Speciality Private Limited U46497KA2025PTC200002 | Director | 21 Mar 2025 | 2025 | Active |
Board colleagues of Srinivasmurthy Ranganath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Geetha Sannadi | 10663579 | Genlyfe Healthcare Private Limited , Jr Vajra Super Speciality Private Limited | Director |
| Ramanamma Konatham | 11359383 | Genlyfe Healthcare Private Limited | Director |
| Chandrasekhar Reddy Bitragunta | 11228332 | Jr Jenika Pharma Private Limited | Director |
| Raju Pramod Bhavya | 11063913 | Jr Jenika Pharma Private Limited | Additional Director |
| Dhakshayani Prakash | 11090384 | Jr Vajra Super Speciality Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivasmurthy Ranganath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivasmurthy Ranganath
Srinivasmurthy Ranganath currently holds 3 directorships: Genlyfe Healthcare Private Limited (Additional Director, since 19 Nov 2025, revenue ₹41.4 Lakh (FY 2024)); Jr Jenika Pharma Private Limited (Director, since 21 Mar 2025); Jr Vajra Super Speciality Private Limited (Director, since 21 Mar 2025).
Srinivasmurthy Ranganath was first appointed on 21 Mar 2025 as Director at Jr Jenika Pharma Private Limited.
The current boards of Srinivasmurthy Ranganath's companies include Geetha Sannadi (Genlyfe Healthcare Private Limited), Ramanamma Konatham (Genlyfe Healthcare Private Limited), Chandrasekhar Reddy Bitragunta (Jr Jenika Pharma Private Limited), Raju Pramod Bhavya (Jr Jenika Pharma Private Limited), Dhakshayani Prakash (Jr Vajra Super Speciality Private Limited).